.jpg?w=340&itok=9QcINfk7 "IPT discussed in technical publications."){kind=icon}
Latest issue out now. Keep up to date on the most recent regulatory changes in the world of pharma, biotech and medical device clinical trials with ICON’s Regulatory Intelligence Newsletter. Join thousands of subscribe...
ICON experts frequently author or contribute to industry trade press.
Filter media
Filter media articles by either clicking within the ‘Category’ drop-down list, or begin typing which will automatically match to the nearest available category. Note - not all categories will display results if selecting a particular year.
-
Clinical Data Management
In this article, Michael Phillips, discusses the ways in which machine learning can replace or augment traditional data review approaches while maintaining a risk-based, patient-centric approach and delivering higher quality outcomes with less human error.
-
LEO Pharma enters clinical trial partnership with ICON
This news article, published on PM Live, highlights how the partnership will advance trial execution within medical dermatology.
-
LEO Pharma and ICON partner for clinical trial execution in dermatology
This news article, published on Clinical Trials Arena, outlines how the collaboration is expected to provide access to innovative clinical trials as well as help to launch new medicines.
-
LEO Pharma and ICON enter strategic partnership
This news article, first published on Applied Clinical Trials, outlines that LEO Pharma and ICON have announced a strategic partnership that will enable LEO Pharma to scale clinical trial execution that is patient-centric and cost effective.
-
ICON and LEO Pharma join forces on clinical trial mission
This news article, published on PharmaTimes online, indicates how the collaboration will concentrate on launching and running studies within medical dermatology.
-
LEO Pharma, ICON partner to advance clinical trials in dermatology
This news article, first published on Contract Pharma, covers the strategic partnership between LEO Pharma and ICON to propel clinical trial execution within medical dermatology.
-
The significant increase in demand for Clinical Research Associates (CRAs)
Helen Yeardley, Senior Vice President, Clinical Operations, offers her insights on the role that a Clinical Trial Associate (CRA) plays in the clinical trial process.
-
.jpg?w=545&itok=pKDORfPh "IPT discussed in technical publications.")
Turning an ocean of data into actionable wisdom to support optimal site identification
Travis Caudill, VP Feasibility & Clinical Informatics, offers his insights on how advancements in AI can help the pharmaceutical industry identify the best sites for their clinical trials through the harnessing of Big Data.
Innovations in Pharmaceutical Technology, December 2022, pages 24-25. Samedan Ltd
-
The evolving relationship between sponsors and contract research organisations
If the last few years have taught us anything, it’s that so much more can be achieved when all players in the life sciences and pharmaceutical industries work together in a truly collaborative way. The opportunity for the clinical development industry is to take what we have learned about how we can work together and use this to continue to drive progress. To strategically support clients, at ICON, this means partnering with sponsors in a way that goes beyond a traditional CRO. It means being a trusted partner.
In this podcast and article Jeff James, EVP Alliance Management, offers his perspective on what it takes to be a trusted partner to sponsors in the clinical development industry. -
Drug development practices to improve public health policy
In this article, Dr Andrew Garrett, Executive Vice President of Scientific Operations, explores the need for interdisciplinary collaboration between pharmaceutical and non-pharmaceutical researchers and public health centres to consider the overlap between NPIs and PIs and identify where standards can be improved and enforced.
